Arax Advisory Partners’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.5K | Buy |
4,378
+1,637
| +60% | +$23.4K | ﹤0.01% | 1135 |
|
|
2025
Q1 | $28.8K | Sell |
2,741
-2,212
| -45% | -$23.2K | ﹤0.01% | 1152 |
|
|
2024
Q4 | $60K | Buy |
4,953
+3,411
| +221% | +$41.3K | ﹤0.01% | 847 |
|
|
2024
Q3 | $22.7K | Buy |
1,542
+1,142
| +286% | +$16.8K | ﹤0.01% | 1037 |
|
|
2024
Q2 | $5.77K | Buy |
+400
| New | +$5.77K | ﹤0.01% | 1527 |
|
|
2022
Q4 | – | Sell |
-4,578
| Closed | -$57K | – | 1292 |
|
|
2022
Q3 | $57K | Buy |
4,578
+3,998
| +689% | +$49.8K | 0.01% | 407 |
|
|
2022
Q2 | $11K | Sell |
580
-2,972
| -84% | -$56.4K | ﹤0.01% | 643 |
|
|
2022
Q1 | $93K | Hold |
3,552
| – | – | 0.01% | 350 |
|
|
2021
Q4 | $101K | Sell |
3,552
-728
| -17% | -$20.7K | 0.01% | 343 |
|
|
2021
Q3 | $136K | Buy |
4,280
+2,478
| +138% | +$78.7K | 0.02% | 277 |
|
|
2021
Q2 | $63K | Buy |
+1,802
| New | +$63K | 0.01% | 436 |
|